active vitamin D — Competitive Intelligence Brief

active vitamin D (active vitamin D) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog. Area: Endocrinology.

phase 3 Vitamin D analog Vitamin D receptor Endocrinology Small molecule

Target snapshot

active vitamin D (active vitamin D) — Kyowa Kirin, Inc.. Active vitamin D works by binding to vitamin D receptors in the body, which helps regulate calcium levels and bone health.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
active vitamin D TARGET	active vitamin D	Kyowa Kirin, Inc.	phase 3	Vitamin D analog	Vitamin D receptor
Cholecalciferol (vitamin D)	Cholecalciferol (vitamin D)	University of Tromso	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Cholecalciferol 12 000 UI	Cholecalciferol 12 000 UI	Assistance Publique - Hôpitaux de Paris	marketed	Vitamin D supplement	Vitamin D receptor (VDR)
Enstilar® foam	Enstilar® foam	Icahn School of Medicine at Mount Sinai	marketed	Topical corticosteroid + vitamin D analog combination	Glucocorticoid receptor; vitamin D receptor (VDR)
calcipotriene + clobetasol propionate	calcipotriene + clobetasol propionate	Leon Kircik, M.D.	marketed	Topical combination therapy (vitamin D analog + corticosteroid)	Vitamin D receptor (VDR) and glucocorticoid receptor (GR)
D3 vitamin	D3 vitamin	Medical University of Lodz	marketed	Vitamin D supplement / Secosteroid	Vitamin D receptor (VDR)
Ibandronate+alfacalcidol+calcium	Ibandronate+alfacalcidol+calcium	Chinese University of Hong Kong	marketed	Bisphosphonate + active vitamin D + mineral supplement combination	Farnesyl pyrophosphate synthase (ibandronate); vitamin D receptor (alfacalcidol); calcium channels (calcium)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog class)

1. LEO Pharma · 2 drugs in this class
2. Genzyme, a Sanofi Company · 2 drugs in this class
3. National Cancer Institute, Naples · 2 drugs in this class
4. OPKO Health, Inc. · 2 drugs in this class
5. Joslin Diabetes Center · 1 drug in this class
6. Kyowa Kirin, Inc. · 1 drug in this class
7. Maimónides Biomedical Research Institute of Córdoba · 1 drug in this class
8. Shanghai Jiao Tong University Affiliated Sixth People's Hospital · 1 drug in this class
9. Shiraz University of Medical Sciences · 1 drug in this class
10. St. Justine's Hospital · 1 drug in this class